Kbp Biosciences Stock

kbpbiosciences.comHealthcareFounded: 2007Funding to Date: $76MM

KBP is a biotechnology company focused on organ, antimicrobial, and immunology research.

Register for Details

For more details on financing and valuation for Kbp Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Kbp Biosciences.

Register Today

Team

Management Team

Robert Segal MD
Deputy Chief Medical Officer
Fred Yang Ph.D
Chief Development Officer
Vince Benn Ph.D
Vice President, Regulatory & Medical Affairs

Board Members

Benjamin Qiu
Bing Wang Ph.D
Frederick Craves Ph.D
Bay City Capital
Huang Zhenhua Ph.D

Other companies like Kbp Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B

News

Clinical-stage biotechnology firm KBP Biosciences has secured a $76 million Series A financing round led by Advantech Capital and SDIC Venture Capital.
KBP Biosciences, a Greater Philadelphia Area and Jinan, China-based private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need, closed a $76m Series A financing. The round was co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay …